Tyers Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$19K Hold
1,232
﹤0.01% 955
2019
Q2
$25K Hold
1,232
﹤0.01% 952
2019
Q1
$22K Hold
1,232
﹤0.01% 952
2018
Q4
$16K Buy
+1,232
New +$16K ﹤0.01% 922